返回列表

会议材料

AAD 2026 - 美国皮肤病学会年会 2026
American Academy of Dermatology
-
美国 · 丹佛

本内容仅供您个人及教育用途。请勿下载或进一步传播。未经版权所有者许可，不得进一步复制或传播

共4条结果
会议壁报
AAD 2026 - 美国皮肤病学会年会 2026 | 皮肤病 | 特应性皮炎 | 希必可
Greater Achievement of Minimal Disease Activity with Abrocitinib vs Dupilumab: An AHEAD Treat-to-Target Analysis of Patients with Moderate-to-Severe Atopic Dermatitis
Gooderham M, Lio P, Ameen M, Katoh N, Biswas P, Encinas G, Watkins M
查看材料原文
会议壁报
AAD 2026 - 美国皮肤病学会年会 2026 | 皮肤病 | 特应性皮炎 | 希必可
Abrocitinib Attenuates Itch-Related Gene Expression in Atopic Dermatitis: Evidence from Lesional and Peri-Lesional Skin Organ Culture and Skin Biopsies from Atopic Dermatitis Patients
Zondler L, Fehrholz M, Pappelbaum K, Piccini I, Edelkamp J, Bertolini M, Watkins M
查看材料原文
会议壁报
AAD 2026 - 美国皮肤病学会年会 2026 | 皮肤病 | 斑秃
Real-World Study in Progress: Characterization and Clinical Outcomes of Alopecia Areata Patients Treated With Ritlecitinib in a Real-World Cohort (PRESTO)
Kindred C, Ito T, Wu W, Asfour L, Hebert V, Sadrarhami M, Gauthier G, Bell G, Law E, Soto AG, Martin C, Schaefer G
查看材料原文
会议壁报
AAD 2026 - 美国皮肤病学会年会 2026 | 皮肤病 | 斑秃
Disease Burden, Treatment Patterns, and Clinical Characteristics of Patients With Alopecia Areata (AA) Treated in United States (US) Community Practices
Sadrarhami M, Gauthier G, Kurosky S, Bell G, Lee YC
查看材料原文
hcp-certification